Literature DB >> 11237308

Assessment of suspected dementia.

H Chertkow1, H Bergman, H M Schipper, S Gauthier, R Bouchard, S Fontaine, A M Clarfield.   

Abstract

At the Second Canadian Consensus Conference on Dementia (CCCD) (February, 1998), a group of neurologists, geriatricians, and psychiatrists met to consider guidelines for evaluation of dementia in Canada. This review paper formed a background paper for their discussion of dementia diagnosis. These experts from across the country concluded that diagnosis of suspected dementia cases continued to rest on skilled clinical assessment. Mental status exam, preferably in some quantifiable form, has become an essential part of the assessment. Selected laboratory tests are advisable in all cases (CBC, TSH, electrolytes, calcium, and glucose), but the CCCD continued to advise that CT scanning was mandatory only in selected cases where clinical findings pointed to another possibility besides Alzheimer's disease. The growing list of other diagnostic measures with potential usefulness in diagnosis of Alzheimer's disease or dementia in general was reviewed, but the evidence was judged as insufficient to support routine use of these tests by physicians. As new treatments for Alzheimer's disease become available, neurologists face new diagnostic challenges--differentiating Mild Cognitive Impairment, Frontotemporal dementias and Mixed dementias, and Lewy Body Dementia. Guidelines to aid in differential diagnosis are presented.

Entities:  

Mesh:

Year:  2001        PMID: 11237308     DOI: 10.1017/s0317167100001189

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  13 in total

1.  Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Georgianne F Tiu; Nicole N Scheff; Marzia Perluigi; Chiara Cini; D Allan Butterfield
Journal:  Brain Res       Date:  2010-04-01       Impact factor: 3.252

2.  Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.

Authors:  Wei Song; Hillel Zukor; Adrienne Liberman; Sagi Kaduri; Zoe Arvanitakis; David A Bennett; Hyman M Schipper
Journal:  Exp Neurol       Date:  2014-01-15       Impact factor: 5.330

Review 3.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

4.  Extending the administration time of the letter fluency test increases sensitivity to cognitive status in aging.

Authors:  Roee Holtzer; Yelena Goldin; Peter J Donovick
Journal:  Exp Aging Res       Date:  2009 Jul-Sep       Impact factor: 1.645

Review 5.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

6.  Structured approach to patients with memory difficulties in family practice.

Authors:  Linda Lee; W Wayne Weston; George Heckman; Micheline Gagnon; F Joseph Lee; Scott Sloka
Journal:  Can Fam Physician       Date:  2013-03       Impact factor: 3.275

7.  [Validation of indicators of the management of cognitive impairment in geriatric assessment units].

Authors:  Isabelle Payot; Judith Latour; Fadi Massoud; Marie-Jeanne Kergoat
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

8.  Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects.

Authors:  Haixiang Su; Mervyn Gornitsky; Guoyan Geng; Ana M Velly; Howard Chertkow; Hyman M Schipper
Journal:  Age (Dordr)       Date:  2008-01-04

Review 9.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

10.  MicroRNA expression in Alzheimer blood mononuclear cells.

Authors:  Hyman M Schipper; Olivier C Maes; Howard M Chertkow; Eugenia Wang
Journal:  Gene Regul Syst Bio       Date:  2007-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.